IGM Biosciences, Inc. (IGMS) earnings
IGMS earnings moved a median of -1.13% by the close. Quarterly and annual IGMS reports and results, each read against the price at its own news timestamp. Back to the IGMS overview →
13 measured IGMS earnings events.
Where these IGMS earnings landedvs 13 measured IGMS earnings reactions
| Middle 50% of IGMS earnings reactions | -3.59% to +3.64% |
|---|---|
| Median reaction (to close) | -1.13% |
| Measured reactions | 13 |
Point-in-time · zero look-ahead
Half of the 13 IGMS earnings events with a measured close landed between -3.59% and +3.64%; 46% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 10-Q IGM Biosciences, Inc. For: Jun 30 | SEC filing · Form 10-Q | +0.78% | +1.55% | |
| Form 10-Q IGM Biosciences, Inc. For: Mar 31 | SEC filing · Form 10-Q | +0.91% | +3.64% | |
| Form 10-K/A IGM Biosciences, Inc. For: Dec 31 | SEC filing · Form 10-K | +0.00% | +5.72% | |
| Form 10-K IGM Biosciences, Inc. For: Dec 31 | SEC filing · Form 10-K | -0.37% | -2.94% | |
| Form 10-Q IGM Biosciences, Inc. For: Sep 30 | SEC filing · Form 10-Q | -0.16% | -7.13% | |
| IGM Biosciences Announces Third Quarter 2024 Financial Results and Provides Corporate Update | Press release | -0.16% | -7.13% | |
| Form 10-Q IGM Biosciences, Inc. For: Jun 30 | SEC filing · Form 10-Q | +0.00% | -1.13% | |
| IGM Biosciences Announces Second Quarter 2024 Financial Results and Provides Corporate Update | Press release | +0.00% | -1.13% | |
| Form 10-Q IGM Biosciences, Inc. For: Mar 31 | SEC filing · Form 10-Q | -0.67% | +13.45% | |
| IGM Biosciences Announces First Quarter 2024 Financial Results and Provides Corporate Update | Press release | -0.67% | +13.45% | |
| Form 10-K IGM Biosciences, Inc. For: Dec 31 | SEC filing · Form 10-K | +1.57% | +0.97% | |
| Form 10-Q IGM Biosciences, Inc. For: Sep 30 | SEC filing · Form 10-Q | +2.39% | -3.59% | |
| IGM Biosciences Announces Third Quarter 2023 Financial Results | Press release | +2.39% | -3.59% |
Keep exploring
More IGMS: analyst actions → · SEC filings → · IGMS overview →